6
Participants
Start Date
May 9, 2022
Primary Completion Date
May 30, 2024
Study Completion Date
May 30, 2024
Trikafta [orange tablet containing ELX 100mg, TEZ 50mg, and IVA 75mg]
Subjects will receive a single dose of trikafta (orange tablet) on day 1 of period 1 and on day 15 of period 2.
Rifabutin 300mg
After washout period greater or equal to 2 days, subjects will receive 300 mg/d of rifabutin on days 1 through 17 of period 2.
University of Southern California, Los Angeles
University of Southern California
OTHER